×
返回 Agenda
Session 2 Track 2: Extrahepatic Delivery 1: Engineering LNPs and Ligand Conjugates for Oligonucleotide Delivery to the Kidney and Lung Tumors
Session Chair(s)
Elena Braithwaite, PHD
Toxicologist, FDA, United States
Jeffrey Foy, PHD
Executive Director, Toxicology, Nimbus Therapeutics, United States
Session 2 Track 2: Extrahepatic Delivery 1: Engineering LNPs and Ligand Conjugates for Oligonucleotide Delivery to the Kidney and Lung Tumors
Speaker(s)
Representative Invited
CEO, EnFuego Therapeutics, United States
Speaker
Representative Invited
CEO and Co-Founder, Barcode Nanotech, Israel
LNP Delivery in the Kidney
Representative Invited
CSO, Judo Bio, United States
siRNA-ligand Conjugates for d=Delivery to the Kidney